Dr. Peter Laier to leave Knorr-Bremse at the end of December 2021

(PresseBox) ( Munich, Germany, )
Dr. Peter Laier, member of the Executive Board of Knorr-Bremse AG and globally responsible for the Commercial Vehicle Systems division (CVS), is to resign from the Executive Board at his own request with effect from December 31, 2021, in order to pursue new professional perspectives. The division will be managed on an interim basis by the CEO Dr. Jan Mrosik from January 1, 2022.

„The Supervisory Board regrets Dr. Laier`s decision to leave the company prematurely. With his departure we are losing a proven expert of the CVS industry and with strong implementation skills“, said Prof. Dr. Klaus Mangold, Chairman of the Supervisory Board of Knorr-Bremse AG. „We would like to thank Dr. Laier for his great commitment. He has made an important contribution to growth and technologic and strategic development of the CVS division. In addition to siginificant global sales growth of the division his achievements are the innovative alignment of the product portfolio as well as the development of the global steering business and, last but not least, the proactive and economically successful management of the CVS division through the Covid-19 pandemic. We wish him every success as he takes his career forward.”

Dr. Peter Laier was appointed to the Executive Board of Knorr-Bremse AG on January 1, 2016 with the responsibility for the global Commercial Vehicle Systems division (CVS). As member of the Executive Board, Dr. Laier also successfully supported the IPO of Knorr-Bremse AG in October 2018. The Supervisory Board of Knorr-Bremse AG has initiated the search for a successor.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.